ConductScience.org, home

Paper528273

The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--I. Adriamycin.

Twentyman PR and 2 others. Int J Radiat Oncol Biol Phys, 1979. Cited by 56 papers, by iCite.

Cite this record

ConductScience Library. The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--I. Adriamycin. Papers, record 528273. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/528273

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--I. Adriamycin.
PubMed
Journal
Int J Radiat Oncol Biol Phys
PubMed
Year
1979
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
3.75
iCite
Revised in PubMed
2019-07-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Twentyman PRP R
2Kallman RFR F
3Brown JMJ M

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DoxorubicinMajor topic
Neoplasms, ExperimentalMajor topic
Animals
Dose-Response Relationship, Radiation
Female
Mice
Mice, Inbred Strains
Sarcoma, Experimental
Time Factors

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
7272187Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.Br J Cancer1981https://conductscience.org/library/papers/7272187PubMed
7150475Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.Br J Cancer1982https://conductscience.org/library/papers/7150475PubMed
7082556Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.Br J Cancer1982https://conductscience.org/library/papers/7082556PubMed
7073938Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.Br J Cancer1982https://conductscience.org/library/papers/7073938PubMed
6871076Chemosensitization by lipophilic nitroimidazoles.Br J Cancer1983https://conductscience.org/library/papers/6871076PubMed
6849803Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.Br J Cancer1983https://conductscience.org/library/papers/6849803PubMed
6824566An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.Br J Cancer1983https://conductscience.org/library/papers/6824566PubMed
6758828Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain.Br J Cancer1982https://conductscience.org/library/papers/6758828PubMed
6722006Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.Br J Cancer1984https://conductscience.org/library/papers/6722006PubMed
6466544Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.Br J Cancer1984https://conductscience.org/library/papers/6466544PubMed
6466543Preclinical pharmacokinetics of benznidazole.Br J Cancer1984https://conductscience.org/library/papers/6466543PubMed
6295428Modification by WR 2721 of the response to chemotherapy of tumours and normal tissues in the mouse.Br J Cancer1983https://conductscience.org/library/papers/6295428PubMed
6264941Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.Br J Cancer1981https://conductscience.org/library/papers/6264941PubMed
3966974Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNU.Br J Cancer1985https://conductscience.org/library/papers/3966974PubMed
3940225CB 1954 revisited. II. Toxicity and antitumour activity.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3940225PubMed
3940216CB 1954 revisited. I. Disposition kinetics and metabolism.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3940216PubMed
3925974The effects of alpha and gamma interferons on human lung cancer cells grown in vitro or as xenografts in nude mice.Br J Cancer1985https://conductscience.org/library/papers/3925974PubMed
3698173Pharmacokinetic basis for the comparative antitumour activity and toxicity of chlorambucil, phenylacetic acid mustard and beta, beta-difluorochlorambucil (CB 7103) in mice.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3698173PubMed
3606940The effects of whole body hyperthermia on the pharmacokinetics and toxicity of the basic 2-nitroimidazole radiosensitizer Ro 03-8799 in mice.Br J Cancer1987https://conductscience.org/library/papers/3606940PubMed
3168141Pharmacokinetics and metabolism of the mixed-function hypoxic cell sensitizer prototype RSU 1069 in mice.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3168141PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/528273

GET https://conductscience.org/api/papers/v1/528273/cited_by?page=2